https://www.selleckchem.com/pr....oducts/aristolochic-
Local recurrence after treatment of ductal carcinoma in situ (DCIS) with breast-conserving surgery (BCS) is more common than after mastectomy, but it is unclear if patterns of invasive recurrence vary by initial surgical therapy. Among patients with invasive recurrence after treatment for DCIS, we compared patterns of first recurrence between those originally treated with BCS vs. mastectomy. From 2000 to 2016, women with an invasive recurrence occurring ≥ 6months after initial treatment for DCIS were retrospectively identifi
Like
Comment
Share
